A study showed that when treatment decisions were made and followed based on Decipher Prostate RP genomic test results, patient outcomes were significantly improved.
Read More
AI-based cancer assessment tools are poised to help pathologists improve the speed and accuracy of cancer diagnostics, ultimately leading to better patient care.
Read More
The partnership combines Caris’ somatic and Ambry’s germline testing to provide unique information about the molecular and genetic components of a patient’s cancer.
Read More
The Medicare LCD provides coverage for the Decipher prostate biopsy genomic test for men with both favorable and unfavorable intermediate-risk prostate cancer.
Read More
The FFPE Tissue Dissociation kit from Miltenyi Biotec offers a standardized protocol for the dissociation of carcinoma samples prior to the enrichment of carcinoma tumor cells for molecular analysis.
Read More